Your browser is no longer supported. Please, upgrade your browser.
PFE Pfizer Inc. daily Stock Chart
Pfizer Inc.
IndexDJIA S&P500 P/E24.87 EPS (ttm)1.45 Insider Own0.10% Shs Outstand6.16B Perf Week5.25%
Market Cap222.05B Forward P/E15.51 EPS next Y2.33 Insider Trans-6.92% Shs Float6.15B Perf Month7.03%
Income9.20B PEG6.45 EPS next Q0.52 Inst Own74.80% Short Float1.11% Perf Quarter6.69%
Sales49.12B P/S4.52 EPS this Y-14.50% Inst Trans-1.30% Short Ratio3.08 Perf Half Y17.37%
Book/sh10.85 P/B3.32 EPS next Y14.03% ROA6.80% Target Price38.24 Perf Year28.91%
Cash/sh4.50 P/C8.01 EPS next 5Y3.86% ROE15.70% 52W Range26.81 - 36.13 Perf YTD17.75%
Dividend1.12 P/FCF34.72 EPS past 5Y3.10% ROI8.90% 52W High-0.19% Beta0.74
Dividend %3.11% Quick Ratio2.20 Sales past 5Y0.10% Gross Margin81.00% 52W Low34.48% ATR0.54
Employees78300 Current Ratio2.40 Sales Q/Q-4.30% Oper. Margin28.50% RSI (14)67.99 Volatility1.99% 1.41%
OptionableYes Debt/Eq0.53 EPS Q/Q8.60% Profit Margin23.40% Rel Volume1.30 Prev Close35.73
ShortableYes LT Debt/Eq0.44 EarningsJul 28 BMO Payout57.90% Avg Volume22.21M Price36.06
Recom2.30 SMA204.14% SMA504.93% SMA20010.18% Volume28,796,214 Change0.92%
Jul-29-15Reiterated Argus Buy $39 → $41
Jun-17-15Initiated Piper Jaffray Overweight
Apr-30-15Reiterated Argus Buy $36 → $39
Apr-29-15Downgrade Citigroup Buy → Neutral
Jan-28-15Reiterated Argus Buy $35 → $36
Dec-18-14Reiterated Deutsche Bank Buy $34 → $35
Jul-02-13Downgrade Standpoint Research Hold → Sell $24
Apr-15-13Reiterated Barclays Equal Weight $25 → $32
Jan-30-13Reiterated UBS Buy $29 → $31
Jan-30-13Reiterated Argus Buy $28 → $32
Jan-22-13Reiterated Barclays Equal Weight $24 → $25
Nov-27-12Downgrade MKM Partners Buy → Neutral $29 → $25
Oct-05-12Reiterated MKM Partners Buy $27 → $29
Nov-01-11Downgrade Standpoint Research Buy → Hold
Oct-07-11Initiated MKM Partners Buy $20.50
Sep-14-11Downgrade Barclays Capital Overweight → Equal Weight $21 → $19
Aug-10-11Upgrade Argus Hold → Buy $21
Aug-05-11Upgrade Standpoint Research Hold → Buy $21
Mar-14-11Downgrade Standpoint Research Buy → Hold
Nov-03-10Downgrade Argus Buy → Hold
Jul-31-15 06:29PM  FDA says hospitals should stop using Hospira pump
06:03PM  Top Drug Stock Pfizer In Buy Area After Earnings Beat at Investor's Business Daily
05:54PM  Your first trade for Monday, August 3 at CNBC
05:26PM  Fast Money Final Trade: XOM, Z, GDX & PFE
01:04PM  PFIZER INC Financials
12:22PM  3 Things You Likely Missed in Pfizer's Q2 Report at Motley Fool
12:08PM  Roche drug maker probed in Romanian graft case
11:35AM  Dow 30 Stock Roundup: Pfizer, P&G, Merck Beat on Earnings, DuPont Misses Estimates - Analyst Blog
10:37AM  Stocks Open Mixed, Dow Lags; Expedia, Amgen, NewLink Rising at Investor's Business Daily
10:34AM  S&P 500 Index Futures Mixed In Choppy Session
10:05AM  4 Merrill Lynch Big, Old and Ugly Stocks To Buy For The Rest Of 2015 at 24/7 Wall St.
Jul-30-15 09:06AM  Novartiss Shares Fall after 2Q15 Earnings
Jul-29-15 04:49PM  Hospira (HSP) Beats on Q2 Earnings Driven by Strong Sales - Analyst Blog
02:15PM  Bull Chart of the Day -- Pfizer Remains Healthy at TheStreet
01:03PM  Big Pharma seeks recreational drug users for clinical trials at Financial Times
12:24PM  Dow adds 100 points as Street awaits Fed statement; earnings eyed at CNBC
09:06AM  Why Alcons Performance Was Weak in 2Q15
08:04AM  Pfizer Pulls The Plug On OTC Lipitor And It's The Patients' Fault at Forbes
07:40AM  Top 10 New Stocks to Trade Like Hedge Fund Renaissance Technologies at TheStreet
07:30AM  Hospira Reports Second-Quarter 2015 Results PR Newswire
06:00AM  The Top Drug Launches Of All Time at Forbes
12:05AM  Pfizers Dollar Dilemma Adds Pressure for Deal Making at The Wall Street Journal
Jul-28-15 09:12PM  Pfizer (PFE) Earnings Report: Q2 2015 Conference Call Transcript at TheStreet
05:32PM  Pfizer, Merck Beat Q2 Views; Sanofi Makes PD-1 Deal at Investor's Business Daily
05:12PM  Gilead higher after earnings beat
05:07PM  Broad rally in the market
04:54PM  Twitter soars on strong results; Yelp tanks at MarketWatch
03:46PM  Pfizer Quits Over-the-Counter Lipitor Program After Trial Fails at Bloomberg
03:43PM  Edited Transcript of PFE earnings conference call or presentation 28-Jul-15 2:00pm GMT
03:41PM  Pfizer chief executive has 'sufficient courage' to pursue deals at Financial Times
03:26PM  Pfizer Eyeing Deals of Any Size in Quest to Find New Blockbuster at Bloomberg
03:04PM  Pfizer's Dollar Dilemma Adds Pressure for Deal Making at The Wall Street Journal
03:01PM  Pfizer Beats Estimates On Strong Cancer Drug Sales at TheStreet
02:42PM  Pfizer Boosts Its Earnings Outlook at The Wall Street Journal
01:35PM  Drugmaker Pfizer tops Street 2Q forecasts, raises forecast
12:00PM  Stocks Higher after Multiday Slide
11:46AM  Why Novartiss Revenues Declined Marginally
10:10AM  Pfizer's revenue, profit beat as vaccine sales rise
10:03AM  Stocks attempt bounce as Fed meeting begins at CNBC
09:45AM  Pfizer (PFE) Stock Climbs on Strong Earnings at TheStreet
09:35AM  Pfizer earnings fall 10% on lower revenue, foreign exchange losses at USA TODAY
09:19AM  Pfizer Beats on Q2 Earnings and Revenues, Revises Outlook - Analyst Blog
09:07AM  What Could Delay Monetary Policy Normalization in the US?
08:57AM  Pfizer beats, Dupont warns; UPS hurt by dollar; Ford soars
08:54AM  Cramer: Hats off to China
08:52AM  PFIZER INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibits
08:38AM  Stock Futures Rebound Ahead of Fed Meeting at TheStreet
08:36AM  Pfizer (PFE) Beats on Q2 Earnings and Revenues - Tale of the Tape
08:36AM  Early movers: F, PFE, MRK, DD, WYN, DHI & more at CNBC
08:33AM  Pfizer, Merck 2Q Profits Beat Estimates
08:32AM  Pfizer, Merck 2Q Profits Beat Estimates at Bloomberg
08:13AM  Wall Street's bounce back; Yellen in spotlight; Trump's $21M penthouse deal
07:44AM  Dissecting big pharma's numbers: Pro
07:42AM  Pfizer Overcomes Currency Exchange Issue with Stronger Sales of Cancer Drugs
07:42AM  Are These 2 Big Pharmas Really Buyout Candidates? at Motley Fool
07:30AM  Pfizer tops Street 2Q forecasts
07:23AM  Morning Movers: Pfizer, Ford Jump on Earnings; DuPont Drops at
07:10AM  Pfizer Profit Beats Estimates as Cancer Drug Sales Increase at Bloomberg
07:10AM  Pfizer shares up as company tops profit, revenue estimates for Q2 at MarketWatch
07:07AM  Q2 2015 Pfizer Inc Earnings Release - Before Market Open
Jul-27-15 09:59PM  Heres A List The Major Companies Reporting Earnings Tuesday
08:15PM  Fed Meeting, Twitter Earnings, Consumer Data in Focus Tuesday at TheStreet
06:25PM  Cramer's shopping list for a pullback
04:20PM  What's in Store for Hospira (HSP) this Earnings Season? - Analyst Blog
04:10PM  Will Currency & Generics Weigh on Pfizer (PFE) Q2 Earnings? - Analyst Blog
04:05PM  Allergan signals appetite for new mega deal after $41bn disposal at Financial Times
02:52PM  What to Watch in the Day Ahead - Tuesday, July 28 Reuters
02:22PM  Merck & Pfizer earnings expectations
02:17PM  What to Look For in Pfizer Earnings
01:15PM  Confluence Life Sciences raises $2.4 million at
01:06PM  Dollar Plagues Pharma Earnings But Did Street Get It Right?
12:01PM  Allergan May Turn Sights to Amgen or AbbVie With Cash From Teva at Bloomberg
11:51AM  Pfizer And Merck Earnings Previews: Mega-Cap Pharmas Try To Stem Revenue Erosion at Insider Monkey
11:43AM  Pfizer (PFE) Stock Falls Ahead of Earnings Release at TheStreet
09:06AM  Lilly continues test of HDL cholesterol drug, on panel's advice Reuters
08:24AM  Teva Buying Allergan Generics For $40.5B As Emerging Markets Boost Drug Spending at Forbes
08:21AM  Short Sellers Run For Cover From Major Pharma at 24/7 Wall St.
07:03AM  3 Questions Wall Street Wants Answered When Pfizer Reports Q2 Results at Motley Fool
06:52AM  What to expect from Merck & Pfizer tomorrow
Jul-26-15 09:40PM  This Healthcare Fund Thinks Large-Caps Are The Best Way To Go at Insider Monkey
03:36PM  Facebook, Twitter And Exxon Mobil Highlight This Week's Earnings
10:21AM  BioPharma Earnings Bracing for Merck, Pfizer, Amgen, Gilead at 24/7 Wall St.
Jul-24-15 09:49PM  They Can Take It If They Want It at The Wall Street Journal
06:31PM  FDA OKs breakthrough cholesterol drug for high-risk patients
03:59PM  What to Watch in the Week Ahead and on Monday, July 27 Reuters
03:19PM  Regeneron: Here's Your Next $12,000 Wonder Drug at
12:45PM  Countdown to health care earnings
Jul-23-15 02:00PM  Pfizers Kendall Square plan will free up one big space but not for long at
12:59PM  Halftime's hottest trades today: Earnings season
12:47PM  Bristol's Earnings Beat Fails to Impress; Shares Fall 1.9% at
12:42PM  How to Trade 5 Big Stocks for Big Gains -- Must-See Charts at TheStreet
12:17PM  Health care on a hot streak
12:15PM  Cancer Drugs Lift Lilly's Outlook at
07:20AM  Getting affordable access to cancer drugs: Eli Lilly CEO
Jul-22-15 04:13PM  What's Coming For Large-Cap Pharma Stocks This Earnings Season?
09:30AM  Zacks Industry Outlook Highlights: AbbVie, Allergan, Pfizer, Juno and Johnson & Johnson - Press Releases
08:30AM  Pfizer Announces Expansion of Lease Agreement with Massachusetts Institute of Technology Subsidiary for Kendall Square Research Facility Business Wire
08:16AM  2015s Top 6 Big Pharma Headlines Thus Far at Motley Fool
07:20AM  Companies rush to sell debt before August at Financial Times
Pfizer Inc., a biopharmaceutical company, discovers, develops, manufactures, and sells healthcare products worldwide. The company operates through Global Innovative Pharmaceutical (GIP); Global Vaccines, Oncology and Consumer Healthcare (VOC); and Global Established Pharmaceutical (GEP) segments. The GIP segment develops, registers, and commercializes medicines for various therapeutic areas, including inflammation, cardiovascular/metabolic, neuroscience and pain, rare diseases, and women's/men's health. The VOC segment develops and commercializes vaccines, as well as products for oncology. It also provides over-the-counter products comprising dietary supplements under the Centrum, Caltrate, and Emergen-C brands; pain management products under the Advil and ThermaCare brands; gastrointestinal products under the Nexium 24HR/Nexium Control brand; respiratory products under the brand names of Robitussin, Advil Cold & Sinus, Advil Congestion Relief, and Dimetapp; and personal care products under the ChapStick and Preparation H brands. The GEP segment offers patent-protected products that have lost marketing exclusivity in various markets; and generic pharmaceuticals, and sterile injectable and biosimilar development products. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as centers for disease control and prevention. It has collaboration with BIND Therapeutics, Inc. to develop and commercialize multiple Accurins. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
OLSON LAURIE JExecutive Vice PresidentJun 11Option Exercise25.8726,000672,62096,113Jun 12 09:26 AM
OLSON LAURIE JExecutive Vice PresidentJun 11Sale34.3926,000894,15570,113Jun 12 09:26 AM
HILL CHARLES HExecutive Vice PresidentMay 29Sale34.9242,8701,497,02069,357Jun 02 04:54 PM
SUSMAN SALLYExecutive Vice PresidentMar 12Sale34.0046,1791,570,086150,899Mar 13 10:39 AM
Dolsten MikaelPresident R&DMar 05Sale34.4658,2982,009,152355,911Mar 06 07:32 PM
READ IAN CChairman & CEOMar 05Sale34.6267,5002,336,7931,408,457Mar 06 07:19 PM
OLSON LAURIE JExecutive Vice PresidentFeb 25Option Exercise17.6921,115373,52481,240Feb 27 06:49 PM
HILL CHARLES HExecutive Vice PresidentFeb 25Option Exercise17.6922,523398,432121,572Feb 27 06:42 PM
JOHNSON RADY AExecutive Vice PresidentFeb 25Option Exercise17.6919,426343,64656,250Feb 27 06:42 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 25Option Exercise17.6932,855581,205141,441Feb 27 06:42 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 25Option Exercise17.69101,3511,792,899227,982Feb 27 06:42 PM
MADDALUNA ANTHONY JExecutive Vice PresidentFeb 25Option Exercise17.6923,649418,35188,933Feb 27 06:42 PM
READ IAN CChairman & CEOFeb 25Option Exercise17.69197,0723,486,2041,568,718Feb 27 06:50 PM
SUSMAN SALLYExecutive Vice PresidentFeb 25Option Exercise17.6995,7211,693,304261,233Feb 27 06:56 PM
YOUNG JOHN DGroup PresidentFeb 25Option Exercise17.6949,364873,249159,673Feb 27 06:56 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 13Option Exercise26.20104,0002,724,800288,775Feb 17 05:50 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 13Sale34.73104,0003,612,323184,775Feb 17 05:50 PM
MADDALUNA ANTHONY JExecutive Vice PresidentFeb 12Sale34.859,000313,66170,252Feb 13 01:50 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 11Sale34.3014,800507,619440,886Feb 12 04:01 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 11Sale34.2380,2002,744,861360,686Feb 12 04:01 PM
MADDALUNA ANTHONY JExecutive Vice PresidentFeb 10Sale33.789,000304,02079,252Feb 11 08:02 PM
LANKLER DOUGLAS MExecutive Vice PresidentDec 31Option Exercise18.1921,413389,502127,673Jan 05 05:17 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerDec 31Option Exercise18.1932,120584,263207,985Jan 05 05:17 PM
HILL CHARLES HExecutive Vice PresidentDec 31Option Exercise18.1926,767486,892126,245Jan 05 05:17 PM
OLSON LAURIE JExecutive Vice PresidentDec 31Option Exercise18.1918,737340,82675,811Jan 05 05:17 PM
YOUNG JOHN DGroup PresidentDec 31Option Exercise18.1926,767486,892128,860Jan 05 05:17 PM
JOHNSON RADY AExecutive Vice PresidentDec 31Option Exercise18.1932,120584,26361,803Jan 05 05:16 PM
MADDALUNA ANTHONY JExecutive Vice PresidentDec 31Option Exercise18.1926,767486,892107,900Jan 05 05:16 PM
BOURLA ALBERTGroup PresidentDec 31Option Exercise18.1916,060292,131113,177Jan 05 05:16 PM
MADDALUNA ANTHONY JExecutive Vice PresidentDec 08Sale32.006,500208,00082,830Dec 09 10:44 AM
HILL CHARLES HExecutive Vice PresidentNov 10Sale30.188,285250,04199,478Nov 10 05:34 PM
YOUNG JOHN DGroup PresidentNov 07Option Exercise26.2021,600565,920123,462Nov 10 05:34 PM
DAMELIO FRANK AExecutive Vice PresidentNov 07Sale29.7807454,687Nov 10 05:34 PM
YOUNG JOHN DGroup PresidentNov 07Sale29.8921,600645,548101,862Nov 10 05:34 PM
READ IAN CChairman & CEOOct 30Option Exercise17.0354,585929,5831,465,906Nov 03 06:23 PM
DAMELIO FRANK AExecutive Vice PresidentOct 30Option Exercise17.0365,5021,115,499501,494Nov 03 06:23 PM
READ IAN CChairman & CEOOct 30Sale29.7667,5002,008,8001,358,862Nov 03 06:23 PM
MADDALUNA ANTHONY JExecutive Vice PresidentOct 29Sale29.562,42571,68388,987Oct 30 06:23 PM